Cd8+ T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade

Transplantation

Volumn 69, Issue 12, 2000, Pages 2609-2612

  Ensminger, Stephan M ^a   Witzke, Oliver ^a   Spriewald, Bernd M ^a   Morrison, Karen ^b   Morris, Peter J ^a   Rose, Marlene L ^b   Wood, Kathryn J ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b HAREFIELD HOSPITAL   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LIGAND BINDING; MORPHOMETRICS; PRIORITY JOURNAL; RECEPTOR BINDING; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THYMECTOMY;

EID: 0034720744     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200006270-00022     Document Type: Article

References (17)

1. Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998; 16: 111.
2. Larsen CP, Alexander DZ, Hollenbaugh D, et al. CD40-gp39 interactions play a critical role during allograft rejection: suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 1996; 61(1): 4.
3. Kirk AD, Harlan DM, Armstrong NN, et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 1997; 94(16): 8789.
4. Kenyon NS, Chatzipetrou M, Masetti M, et al. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci USA 1999; 96(14): 8132.
5. Kirk AD, Burkly LC, Batty DS, et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999; 5(6): 686.
6. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381(6581): 434.
7. Sun H, Subbotin V, Chen C, et al. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation 1997; 64(12): 1838.
8. Larsen CP, Pearson TC. The CD40 pathway in allograft rejection, acceptance, and tolerance. Curr Opin Immunol 1997; 9: 641.
9. Koulack J, McAlister VC, Giacomantonio CA, Bitter-Suermann H, MacDonald AS, Lee TD. Development of a mouse aortic transplant model of chronic rejection. Microsurgery 1995; 16(2): 110.
10. Turvey SE, Hara M, Morris PJ, Wood KJ. Mechanisms of tolerance induction after intrathymic islet injection: determination of the fate of alloreactive thymocytes. Transplantation 1999; 68(1): 30.
11. Noelle R, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, Aruffo A. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci USA 1992; 89(14): 6550.
12. Cobbold SP, Jayasuriya A, Nash A, Prospero TD, Waldmann H. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 1984; 312(5994): 548.
13. Akyurek LM, Johnsson C, Lange D, et al. Tolerance induction ameliorates allograft vasculopathy in rat aortic transplants: influence of Fas-mediated apoptosis. J Clin Invest 1998; 101(12): 2889.
14. Subbotin V, Sun H, Aitouche A, et al. Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance. Transplantation 1997; 64(5): 690.
15. + T-helper and a T-killer cell. Nature 1998; 393(6684): 474.
16. Whitmire J, Slifka MK, Grewal IS, Flavell RA, Ahmed R. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection. J Virol 1996; 70(12): 8375.
17. + type 2 cytotoxic T cells restricts their potential B cell helper activity. Eur J Immunol 1997; 27(4): 914.